Patient and Societal Preferences for On-demand Treatment in Hereditary Angioedema: Estimation of Utility Using a Discrete Choice Experiment

Kalvista Pharmaceuticals Inc. published this content on November 11, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 11, 2025 at 18:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]